Pharmazz Inc. Announces Two Presentations on Sovateltide as a Treatment for Acute Ischemic Stroke at the 14th World Stroke Congress

WILLOWBROOK, Ill., Oct. 26, 2022 (GLOBE NEWSWIRE) — Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care, announced two presentations on sovateltide as a treatment for acute ischemic stroke at the 14th World Stroke Congress October 26-29, 2022, in Singapore.

Details for the presentations are as follows:

Title: A Randomized Multicenter Study to Determine The Efficacy of Sovateltide (Tycamzzi™) in Patients With Cerebral Ischemic Stroke
Presentation: Oral Presentation, #1714
Authors: A. Gulati (presenter), S. Adwani, V. Pamidimukkala, N. Agrawal, T. Ramakrishnan, H. Rai, D. Jain, N.Sundarachary, J. Pandian, V. Sardana, M. Sharma, G. Sidhu, S. Anand, D. Vibha, S. Aralikatte, D. Khurana, D. Joshi, U. Karadan, M. Imam
Session: 1200 – Free Communications 18: Clinical Trials I
Time/Date: 11:30 a.m. – 1 p.m. GMT+8, Saturday, October 29, 2022 (Singapore) / 11:30 p.m. – 1 a.m. EDT, Friday, October 28, 2022 (U.S.)
   
Title: Sovateltide (Tycamzzi™) Induces Neuronal Regeneration in The Adult Mammalian Cerebral Ischemic Brain By Stimulating Endothelin B Receptors
Presentation: E-Poster Presentation, #1763
Authors: A. Gulati (presenter), A. Ranjan, S. Briyal
Session: 0150 – Short Communications 02: Etiology and Clinical Presentations 02
Time/Date: 10 – 11:30 a.m. GMT+8, Wednesday, October 26, 2022 (Singapore) / 10 – 11:30 p.m. EDT, Tuesday, October 25, 2022 (U.S.)

About Pharmazz, Inc. 
Pharmazz, Inc. is a privately held company engaged in developing novel products in critical care medicine. Additional information may be found on the Company’s website, www.pharmazz.com.  

Media contacts:
Katie Larch / Robert Flamm, Ph.D.
Burns McClellan, Inc.
Email: klarch@burnsmc.com / rflamm@burnsmc.com

Investor contacts:
Eric Ando
Burns McClellan, Inc.
Email: eando@burnsmc.com

Shruti Gulati
Pharmazz Inc.
Email: shruti.gulati@pharmazz.com 
Phone: (630) 780-6087

 

Staff

Recent Posts

The Doctor and The Athlete: Powerhouse Duo Disrupts Functional Beverage Market with Science-Backed “Happiness”

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ -- Happy Panda announces its official market launch with a…

8 hours ago

FUGO Precision 3D to Debut Revolutionary Centrifugal 3D Printing Technology with Live Demonstrations at LMT LAB DAY Chicago 2026

GARDENA, Calif., Feb. 2, 2026 /PRNewswire/ -- FUGO Precision 3D, developer of the world's first all-in-one…

8 hours ago

The Micro-Mechanics of Modern Oral Care

OXNARD, CA / ACCESS Newswire / February 2, 2026 / Quality Dental Services functions as…

11 hours ago

Dr. Shahrooz Yazdani Launches $6M Dental Practice Seminar Series to Help Owners Break Free from Burnout

Seminar offers step-by-step blueprint to grow your clinic, build passive income, and regain personal timeOTTAWA,…

14 hours ago

New Aura and UNC-Chapel Hill Study Finds One in Three Kids Have Accessed GenAI Apps

BOSTON, Feb. 2, 2026 /PRNewswire/ -- Aura, a leading AI-powered online safety platform for families,…

14 hours ago